Merck Selects Reval

New York, September 12, 2011 – Reval, the leading global provider of corporate financial risk management solutions, announced today that Merck (NYSE:MRK), known as MSD outside the United States and Canada, has selected Reval’s Software-as-a-Service solution to support its foreign exchange and interest rate derivative portfolios.

“We are thrilled to work with such a quality, global company on its initiative to bring together all of its processes for exposure management, derivative management and hedge accounting onto a single, integrated workflow using Reval,” says Jeff Stacey, Reval’s Managing Director, Americas.

Merck and Schering-Plough merged in November 2009 to create a new company that today is the second-largest healthcare company in the world.

For more information about Reval, please contact

Other suggested links:

About Reval

Reval is a global SaaS provider for Treasury and Risk Management, helping enterprises better manage cash, liquidity and financial risk, and account for and report on complex financial instruments and hedging activities.

For more information, visit or email

Note to editors: Trademarks and registered trademarks remain the property of their respective owners.